Benjamin Shaker - 20 Jul 2022 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Markets Officer
Signature
/s/ Timothy Bensley, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
20 Jul 2022
Transactions value $
-$2,655,253
Form type
4
Filing time
22 Jul 2022, 16:07:56 UTC
Previous filing
29 Sep 2022
Next filing
21 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Sale -$1,197,464 -45,442 -58.7% $26.35 32,014 20 Jul 2022 Direct F1, F2, F3
transaction AGL Common Stock Sale -$121,614 -4,558 -14.2% $26.68 27,456 20 Jul 2022 Direct F1, F3, F4
transaction AGL Common Stock Options Exercise $49,676 +49,676 +181% $1.00* 77,132 21 Jul 2022 Direct F3
transaction AGL Common Stock Sale -$1,078,838 -39,052 -50.6% $27.63 38,080 21 Jul 2022 Direct F1, F3, F5
transaction AGL Common Stock Sale -$307,011 -10,948 -28.8% $28.04 27,132 21 Jul 2022 Direct F1, F3, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -49,676 -13.2% $0.000000 327,306 21 Jul 2022 Common Stock 49,676 $1.00 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.63 to $26.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Includes restricted stock units.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.63 to $26.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.92 to $27.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.92 to $28.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 These options were granted on December 30, 2016, and became fully vested as of January 12, 2021.